Liminal BioSciences

-$0.07 (-2.13%) As of 4:52 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LMNL and other ETFs, options, and stocks.

About LMNL

Liminal BioSciences, Inc. is a biopharmaceutical corporation. The firm engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer.

CEO
Bruce Philip Pritchard
Employees
251
Headquarters
Laval, Québec
Founded
1994

LMNL Key Statistics

Market Cap
139.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
231.67K
High Today
$3.28
Low Today
$3.17
Open Price
$3.24
Volume
209.72K
52 Week High
$24.56
52 Week Low
$3.17

LMNL Earnings

-$1.25
-$0.83
-$0.42
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure